Literature DB >> 9639514

Naturally occurring mutations in glycoprotein Ibalpha that result in defective ligand binding and synthesis of a truncated protein.

D Kenny1, O G Jónsson, P A Morateck, R R Montgomery.   

Abstract

The platelet GPIb-V-IX complex is the receptor for the initial binding of von Willebrand factor (vWF) mediating platelet adhesion. The complex is composed of four membrane-spanning glycoproteins (GP): GPIbalpha, GPIbbeta, GPIX, and GPV. Bernard-Soulier syndrome results from a qualitative or quantitative defect in one or more components of the platelet membrane GPIb-V-IX complex. We describe the molecular basis of a novel Bernard-Soulier syndrome variant in two siblings in whom GPIbalpha was not detected on the platelet surface but that was present in a soluble form in plasma. DNA sequence analysis showed that the affected individuals were compound heterozygotes for two mutations. One, inherited from a maternal allele, a T777 --> C point mutation in GPIbalpha converting Cys65 --> Arg within the second leucine rich repeat, the other, a single nucleotide substitution (G2078 --> A) for the tryptophan codon (TGG) causing a nonsense codon (TGA) at residue 498 within the transmembrane region of GPIbalpha, inherited from a mutant paternal allele. The Bernard-Soulier phenotype was observed in siblings who were compound heterozygotes for these two mutations. Although GPIbalpha was not detected on the surface of the patient's platelets, soluble GPIbalpha could be immunoprecipitated from plasma. When plasmids encoding GPIbalpha containing the Cys65 --> Arg mutation were transiently transfected into Chinese hamster ovary (CHO) cells stably expressing the GPbeta-IX complex (CHObetaIX), the expression of GPIbalpha was similar to the wild-type (WT) GPIbalpha, but did not bind vWF. When plasmids encoding GPIbalpha containing the Trp498 --> stop were transiently transfected into CHObetaIX, the surface expression of GPIbalpha was barely detectable compared with the WT GPIbalpha. Thus, this newly described compound heterozygous defect produces Bernard-Soulier syndrome by a combination of synthesis of a nonfunctional protein and of a truncated protein that fails to insert into the platelet membrane and is found circulating in plasma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639514

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Biosynthesis and intracellular post-translational processing of normal and mutant platelet glycoprotein GPIb-IX.

Authors:  P Ulsemer; C Strassel; M J Baas; J Salamero; S Chasserot-Golaz; J P Cazenave; C De La Salle; F Lanza
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.

Authors:  Dermot Kenny; Clare Muckian; Desmond J Fitzgerald; Christopher P Cannon; Denis C Shields
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

Review 3.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

4.  A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis.

Authors:  Silvia Vettore; Fabiana Tezza; Alessandro Malara; Fabrizio Vianello; Alessandro Pecci; Raffaella Scandellari; Matteo Floris; Alessandra Balduini; Fabrizio Fabris
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

5.  Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome.

Authors:  S Kanaji; S A Fahs; J Ware; R R Montgomery; Q Shi
Journal:  J Thromb Haemost       Date:  2014-08-26       Impact factor: 5.824

6.  Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.

Authors:  Sachiko Kanaji; Erin L Kuether; Scot A Fahs; Jocelyn A Schroeder; Jerry Ware; Robert R Montgomery; Qizhen Shi
Journal:  Mol Ther       Date:  2011-11-01       Impact factor: 11.454

7.  Diagnosis and Management of Inherited Platelet Disorders.

Authors:  Carl Maximilian Kirchmaier; Daniele Pillitteri
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

8.  Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.

Authors:  Y Li; H Choi; Z Zhou; L Nolasco; H J Pownall; J Voorberg; J L Moake; J-F Dong
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

Review 9.  Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).

Authors:  François Lanza
Journal:  Orphanet J Rare Dis       Date:  2006-11-16       Impact factor: 4.123

10.  Abnormal whole blood thrombi in humans with inherited platelet receptor defects.

Authors:  Francis J Castellino; Zhong Liang; Patrick K Davis; Rashna D Balsara; Harsha Musunuru; Deborah L Donahue; Denise L Smith; Mayra J Sandoval-Cooper; Victoria A Ploplis; Mark Walsh
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.